Pneumothorax during lenvatinib plus pembrolizumab for recurrent endometrial cancer: A case report

已完结 10 由士多啤梨发布于 2026/8/28 10:28:53

DOI:10.1016/j.tjog.2025.03.016
作者：Masahiro Taguchi,?Yoshifumi Takahashi,?Miku Nakamura,?Yuji Takei,?Hiroyuki Fujiwara
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：ObjectivePneumothorax is a rare adverse event in cancer treatment. Lenvatinib, a multi-kinase inhibitor with antiangiogenic activity, may cause organ perforation. We present a case of pneumo

应助信息

1天前

亮露

3f965e11a28811f1b789208810ba6e4f.pdf 已采纳

1天前

Book学术机器人

2026/8/28 10:28:54 未找到该文献，机器人已退出，请等待人工下载

2026/8/28 10:28:53 Book学术AI机器人收到请求，开始寻找文献

2026/8/28 10:28:53 已向机器人发送请求

1天前

士多啤梨发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Wolters Kluwer OvidImmune Checkpoint Inhibitor Pneumonitis: Implications for Definitive Breast Cancer Reconstruction.